Affiliation: Hospital de Sabadell
- Physiologic parameters as biomarkers: what can we learn from physiologic variables and variation?Ricard Ferrer
Critical Care Center, Hospital de Sabadell, Parc Tauli s n, 08208 Sabadell, Spain
Crit Care Clin 27:229-40. 2011..Physiologic variability of heart rate and body temperature is reduced in sepsis and measuring the variability of these parameters can be useful for the diagnosis and prognosis of sepsis...
- Effectiveness of treatments for severe sepsis: data from the bundle implementation programsR Ferrer
Critical Care Center, Hospital de Sabadell, CIBER Enfermedades Respiratorias, Instituto Universitario Parc Tauli, Universidad Autonoma de Barcelona, Spain
Minerva Anestesiol 77:360-5. 2011..Hospitals should recognize this new evidence and design strategies to guarantee bundled care for severe sepsis...
- Improvement in process of care and outcome after a multicenter severe sepsis educational program in SpainRicard Ferrer
Centro de Críticos, Hospital de Sabadell, CIBER Enfermedades Respiratorias, Instituto Universitario Parc Tauli, Universidad Autonoma de Barcelona, Barcelona, Spain
JAMA 299:2294-303. 2008..Concern exists that current guidelines for care of patients with severe sepsis and septic shock are followed variably, possibly due to a lack of adequate education...
- [Role of coagulation in acute pulmonary lesion physiopathology. Parallelism with sepsis]R Ferrer
Centro de Críticos, Hospital de Sabadell, Corporación Sanitaria Parc Taulí, CIBER Enfermedades Respiratorias, Instituto Universitario Parc Tauli, Universidad Autonoma, Barcelona, Espana
Med Intensiva 32:304-11. 2008....
- Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational studyRicard Ferrer
Critical Care Center, Hospital de Sabadell, CIBER Enfermedades Respiratorias, Universidad Autonoma de Barcelona, Sabadell, Spain
Am J Respir Crit Care Med 180:861-6. 2009..Several Surviving Sepsis Campaign Guidelines recommendations are reevaluated...
- Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in SpainDavid Suarez
Unidad de Epidemiología y Evaluación, Instituto Universitario Fundación Parc Tauli, Universidad Autonoma de Barcelona, Sabadell Barcelona, Spain
Intensive Care Med 37:444-52. 2011..Severe sepsis is associated with high mortality and increased costs. The 'Surviving Sepsis Campaign' (SSC) protocol was developed as an international initiative to reduce mortality. However, its cost-effectiveness is unknown...
- Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumoniaMalina Ioanas
Institut Clinic de Pneumologia i Cirurgia Toracica, Hospital Clinic, Barcelona, Spain
Crit Care Med 32:938-45. 2004..To prospectively evaluate the predictive factors for the nonresponse to empirical antibiotic treatment and mortality in patients with intensive care unit-acquired pneumonia...
- Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilatedJordi Valles
Critical Care Center, Hospital Sabadell, Consorci Hospitalari Universitari Parc Taulí, CIBER Enfermedades Respiratorias, Sabadell, Spain
Chest 143:1219-25. 2013..Comatose patients were studied to evaluate the efficacy of a single-dose of antibiotic prophylaxis at intubation against EO-VAP...
- The impact of a quality improvement intervention to reduce nosocomial infections in a PICUElisabeth Esteban
Pediatric Intensive Care Unit, Hospital Sant Joan de Deu, Barcelona, Spain
Pediatr Crit Care Med 14:525-32. 2013..To evaluate whether a quality improvement intervention could reduce nosocomial infection rates in a PICU and improve patient outcomes...
- Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement programRicard Ferrer
1Department of Intensive Care, Mútua Terrassa University Hospital, CIBER Enfermedades Respiratorias, Barcelona, Spain 2Critical Care Center, Sabadell Hospital, CIBER Enfermedades Respiratorias, Corporación Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain 3The Ohio State University Center for Biostatistics, Columbus, OH 4Department of Surgery and Emergency Medicine, Division of Acute Care Surgery, Surgical Trauma Critical Care, Barnes Jewish Hospital, Washington University, St Louis, MO 5California Pacific Medical Center, San Francisco, CA 6Brown University Rhode Island Hospital, Providence, RI 7Cooper University Hospital, Camden, NJ
Crit Care Med 42:1749-55. 2014..To perform a retrospective analysis on the Surviving Sepsis Campaign database to evaluate the relationship between timing of antibiotic administration and mortality...
- Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridgeElisabeth Esteban
Pediatric Intensive Care Unit, Hospital Sant Joan de Deu, Passeig Sant Joan de Deu, 2 08950, Universitat de Barcelona, Esplugues de Llobregat, Barcelona, Spain
Mediators Inflamm 2013:507539. 2013..In this paper, we summarize the immune modulation actions of Polymyxin B-immobilized cartridge to explore its potential usefulness beyond endotoxin elimination. ..
- Effectiveness of an inspiratory pressure-limited approach to mechanical ventilation in septic patientsIgnacio Martin-Loeches
Critical Care Centre, Corporación Sanitaria Universitaria Parc Tauli, Sabadell University Hospital, Universidad Autonoma de Barcelona, CIBER Enfermedades Respiratorias, Sabadell, Spain
Eur Respir J 41:157-64. 2013..84, 95% CI 0.72-0.99; p=0.038). ALI in sepsis was associated with higher mortality, especially when an inspiratory pressure-limited mechanical ventilation approach was not implemented...
- Treatment strategies for central venous catheter infectionsCaroline Sabatier
Hospital de Sabadell, Centre de Critics, Intensive Care Unit, Sabadell, Spain
Expert Opin Pharmacother 10:2231-43. 2009..Glycopeptide antibiotics are widely used for empirical treatment because of the high prevalence of staphylococcal infections. Antibiotic therapy should be reassessed when culture and sensitivity results are known...
- Bloodstream infection in the ICUJordi Valles
Critical Care Center, Hospital Sabadell, Institut Universitari Parc Tauli UAB, CIBER Enfermedades Respiratorias, Parc Tauli s n, Sabadell 08208, Spain
Infect Dis Clin North Am 23:557-69. 2009..This article discusses the clinical importance of BSI, including hospital- and community-acquired episodes in the ICU...
- Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*Jean Louis Vincent
1Department of Intensive Care, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium 2Apex Bioscience, Inc, Chapel Hill, NC 3Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom 4CIBER Enfermedades Respiratorias, Getafe University Hospital, Universidad Europea, Madrid, Spain 5Curacyte AG, Munich, Germany 6Department of Anesthesiology, Intensive Care Medicine and Pain Management, HELIOS Klinikum Erfurt GmbH, Erfurt, Germany 7Klinik fur Kardiologie, Angiologie and konservative Intensivmedizin, Vivantes Klinikum Neukoelln, Berlin, Germany 8Intensive Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain 9CIBER Enfermedades Respiratorias, Terrassa, Barcelona, Spain 10Department of Intensive Care ICU, Hospital Universitari Dr Josep Trueta, Girona, Spain 11Department of Intensive Care, RWTH University Hospital Aachen, Aachen, Germany
Crit Care Med 43:57-64. 2015..To compare the effectiveness and safety of the hemoglobin-based nitric oxide scavenger, pyridoxalated hemoglobin polyoxyethylene, against placebo in patients with vasopressor-dependent distributive shock...
- Clinical review: non-antibiotic strategies for preventing ventilator-associated pneumoniaRicard Ferrer
Centre de Critics, Hospital de Sabadell, Barcelona, Spain
Crit Care 6:45-51. 2002..The appropriate use of these techniques can reduce the incidence of NP in intensive care unit patients...